This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,081.76 contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which provides a comprehensive global...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,861.05 firm fixed-price contract is for the supply of the prescription medication Quillivant XR 25 mg/5 ml suspension in 120 ml bottles, with a period of performance through April 23, 2025. The contract is not designated as a set-aside, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension (120 ml). The contract has a ceiling value of $1,304.07 and a period of performance through May 20, 2025. The contract is not set aside and was awarded on May 19, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract...
This is a $5,021.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of Quillivant XR 25 mg/5 ml suspension, a prescription medication. The order has an ultimate completion date of March 3, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension in 60 ml bottles, with a ceiling value of $1,492.11 and a period of performance through March 6, 2025. The contract was not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract...
This is a $6,097.44 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 60 ml bottles of Quillivant XR 25 mg/5 ml oral suspension medication. The contract does not have a set-aside designation and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a prescription medication, with a ceiling value of $3,276.66 and a completion date of January 22, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a $1,777.05 firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 3, 2025. This appears to be a component of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The award, with a ceiling value of $1,270.30 and a completion date of March 21, 2024, is for the supply of Quillivant XR 25 mg/5 ml suspension medication. The contract is part of AmerisourceBergen Drug Corp's broader role as the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication, with a ceiling value of $2,379.46 and a period of performance ending on May 16, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite...